Work

Abstract PS2-09-29: Validity of the p53 antibody DO-7 as a surrogate for predicting TP53 mutation status in breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-09-29

Authors: J. Van Allen, A. Alvarez Soto, P. Hegde, M. Sanders, K. Claffey, B. Malowitz, S. Tannenbaum

Institutions: University of Connecticut, UConn Health

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130713025

Cites:

Cited by:

Related to: